Snowden Capital Advisors LLC Synthetic Biologics, Inc. Transaction History

Snowden Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jan 08, 2024	SELL	$2.8 - $5.7 $129,628 - $263,887	-46,296 Closed	0 $0
Q1 2020 Jan 08, 2024	SELL	$2.7 - $6.1 $12.4 Million - $28 Million	-4,583,304 Reduced 99.0%	46,296 $14.9 Million
Q3 2019 Jan 30, 2024	BUY	$3.9 - $5.9 $180,554 - $273,146	46,296 New	46,296 $21 Million
Q3 2019 Jan 08, 2024	BUY	$3.9 - $5.9 $18 Million - $27.3 Million	4,619,600 Added 46196.0%	4,629,600 $21 Million
Q2 2019 Jan 08, 2024	BUY	$4.9 - $6.6 $49,000 - $66,000	10,000 New	10,000 $4.1 Million

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.